Selecta continues its tour around France with another collaboration

By Lourdes Riquelme

Selecta Biosciences and Généthon are collaborating to enable repeat dosing for gene therapies. The companies are combining Généthon’s expertise in the development of gene therapy vectors and Selecta’s Synthetic Vaccine Particle platform to prevent undesired immune responses. Selecta seems quite fond of collaborating with French companies. After allying with Sanofi, Lire la suite

Source:: Labiotech

Les commentaires sont clos.